“Bimekizumab Safety in Patients With Psoriasis Achieving Complete Skin Clearance: 4-Year Analysis from 5 Phase 3 3b Trials”. 2026. SKIN The Journal of Cutaneous Medicine 10 (2): s757. https://doi.org/10.25251/v6wwxw80.